Literature DB >> 18241614

Genetic links between diabetes mellitus and coronary atherosclerosis.

Jose M Ordovas1.   

Abstract

Diabetes mellitus is one of the most common endocrine disorders. It affects almost 6% of the world's population, and its prevalence continues to increase. The causes of diabetes mellitus are multifactorial, and in the general population both genetic and environmental factors contribute evenly to its development. Several genes have been consistently associated with type 2 diabetes mellitus; however, it is not clear how many of those translate into increased cardiovascular disease risk. Recent evidence suggests that genetic variation at the CALPN10, FABP4, GK, GST, PPARA, and PPARG loci may confer higher cardiovascular disease risk in patients with type 2 diabetes mellitus. However, the evidence is scattered and inconclusive and its translation into practical clinical testing will require studies properly designed to examine not only simple genetic associations but also gene-gene and gene-environment interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18241614     DOI: 10.1007/s11883-007-0020-9

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  35 in total

1.  Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study.

Authors:  Alex S F Doney; Simon Lee; Graham P Leese; Andrew D Morris; Colin N A Palmer
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

2.  The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants.

Authors:  E Levy; D Ménard; E Delvin; S Stan; G Mitchell; M Lambert; E Ziv; J C Feoli-Fonseca; E Seidman
Journal:  J Biol Chem       Date:  2001-08-03       Impact factor: 5.157

3.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.

Authors:  Y Horikawa; N Oda; N J Cox; X Li; M Orho-Melander; M Hara; Y Hinokio; T H Lindner; H Mashima; P E Schwarz; L del Bosque-Plata; Y Horikawa; Y Oda; I Yoshiuchi; S Colilla; K S Polonsky; S Wei; P Concannon; N Iwasaki; J Schulze; L J Baier; C Bogardus; L Groop; E Boerwinkle; C L Hanis; G I Bell
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

4.  A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2.

Authors:  C L Hanis; E Boerwinkle; R Chakraborty; D L Ellsworth; P Concannon; B Stirling; V A Morrison; B Wapelhorst; R S Spielman; K J Gogolin-Ewens; J M Shepard; S R Williams; N Risch; D Hinds; N Iwasaki; M Ogata; Y Omori; C Petzold; H Rietzch; H E Schröder; J Schulze; N J Cox; S Menzel; V V Boriraj; X Chen; L R Lim; T Lindner; L E Mereu; Y Q Wang; K Xiang; K Yamagata; Y Yang; G I Bell
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

5.  Chromosome 4q locus associated with insulin resistance in Pima Indians. Studies in three European NIDDM populations.

Authors:  P Humphreys; M McCarthy; J Tuomilehto; E Tuomilehto-Wolf; I Stratton; R Morgan; A Rees; D Owens; J Stengård; A Nissinen
Journal:  Diabetes       Date:  1994-06       Impact factor: 9.461

Review 6.  Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.

Authors:  Philippe Lefebvre; Giulia Chinetti; Jean-Charles Fruchart; Bart Staels
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

7.  A futile metabolic cycle activated in adipocytes by antidiabetic agents.

Authors:  Hong-Ping Guan; Yong Li; Mette Valentin Jensen; Christopher B Newgard; Claire M Steppan; Mitchell A Lazar
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

Review 8.  The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis.

Authors:  Dolores Corella; Jose M Ordovas
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

9.  Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels.

Authors:  Coleen M Damcott; Eleanor Feingold; Susan P Moffett; M Michael Barmada; Julie A Marshall; Richard F Hamman; Robert E Ferrell
Journal:  Hum Genet       Date:  2003-03-13       Impact factor: 4.132

10.  An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance.

Authors:  L J Baier; J C Sacchettini; W C Knowler; J Eads; G Paolisso; P A Tataranni; H Mochizuki; P H Bennett; C Bogardus; M Prochazka
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

View more
  10 in total

1.  Calpain-10 is a component of the obesity-related quantitative trait locus Adip1.

Authors:  James M Cheverud; Gloria L Fawcett; Joseph P Jarvis; Elizabeth A Norgard; Mihaela Pavlicev; L Susan Pletscher; Kenneth S Polonsky; Honggang Ye; Graeme I Bell; Clay F Semenkovich
Journal:  J Lipid Res       Date:  2010-05       Impact factor: 5.922

Review 2.  Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Cell Mol Life Sci       Date:  2017-04-21       Impact factor: 9.261

3.  Replication of calpain-10 genetic association with carotid intima-media thickness.

Authors:  Mark O Goodarzi; Kent D Taylor; Michelle R Jones; Belle Fang; Xiuqing Guo; Anny H Xiang; Thomas A Buchanan; Howard N Hodis; Leslie J Raffel; Jerome I Rotter
Journal:  Atherosclerosis       Date:  2009-01-09       Impact factor: 5.162

4.  High-density real-time PCR-based in vivo toxicogenomic screen to predict organ-specific toxicity.

Authors:  Gabriella Fabian; Nora Farago; Liliana Z Feher; Lajos I Nagy; Sandor Kulin; Klara Kitajka; Tamas Bito; Vilmos Tubak; Robert L Katona; Laszlo Tiszlavicz; Laszlo G Puskas
Journal:  Int J Mol Sci       Date:  2011-09-19       Impact factor: 5.923

Review 5.  Metabolic syndrome: definitions and controversies.

Authors:  Eva Kassi; Panagiota Pervanidou; Gregory Kaltsas; George Chrousos
Journal:  BMC Med       Date:  2011-05-05       Impact factor: 8.775

Review 6.  A comprehensive review on metabolic syndrome.

Authors:  Jaspinder Kaur
Journal:  Cardiol Res Pract       Date:  2014-03-11       Impact factor: 1.866

7.  Serum metabolic profiles in overweight and obese women with and without metabolic syndrome.

Authors:  Petri K Wiklund; Satu Pekkala; Reija Autio; Eveliina Munukka; Leiting Xu; Juha Saltevo; Shumei Cheng; Urho M Kujala; Markku Alen; Sulin Cheng
Journal:  Diabetol Metab Syndr       Date:  2014-03-20       Impact factor: 3.320

Review 8.  Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  J Atheroscler Thromb       Date:  2017-08-17       Impact factor: 4.928

9.  Observational study of the status of coronary risk biomarkers among Negritos with metabolic syndrome in the east coast of Malaysia.

Authors:  Atiqah Mokhsin; Siti Shuhada Mokhtar; Aletza Mohd Ismail; Fadzilah M Nor; Syahrul Azlin Shaari; Hapizah Nawawi; Khalid Yusoff; Thuhairah Abdul Rahman; Boon Peng Hoh
Journal:  BMJ Open       Date:  2018-12-04       Impact factor: 2.692

10.  Plasma advanced oxidative protein products are associated with anti-oxidative stress pathway genes and malaria in a longitudinal cohort.

Authors:  Guicheng Zhang; Oleksii A Skorokhod; Siew-Kim Khoo; Ruth Aguilar; Selma Wiertsema; Augusto J Nhabomba; Tiziana Marrocco; Michelle McNamara-Smith; Maria Nelia Manaca; Arnoldo Barbosa; Llorenç Quintó; Catherine M Hayden; Jack Goldblatt; Caterina Guinovart; Pedro L Alonso; Carlota Dobaño; Evelin Schwarzer; Peter N LeSouëf
Journal:  Malar J       Date:  2014-04-03       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.